We spared chemotherapy in likely non-responder patient population such as elderly or frail glioblastoma (GBM) patients with unmethylated MGMT promoter, as well as taking into account an hypofractionated radiotherapy approach to reduce the number of patients' access to the Hospital (14, 15). Here, MGMT is linked to glioblastoma.